The review board will re-examine Avigan's effectiveness once additional data is submitted, the ministry said.Fujifilm has been seeking approval for its antiviral drug Avigan as a treatment for COVID-19 in Japan since October after its late-stage study showed faster recovery time for patients with non-severe symptoms.
In a single-blinded clinical trial, doctors know whether patients are given an actual drug or a placebo, and the results of such trials tend to be less objective than those of double-blinded tests, in which neither doctors nor patients have such knowledge, the official said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: